Stem Cell & Regenerative · Patient guide

Vaginal Stem Cell Therapy vs Exosomes: What Is the Difference?

Stem cell therapy injects living cells, taken from your fat or bone marrow or from a donor; exosomes are tiny cell-free vesicles released by cells, usually from donor or plant sources, carrying proteins and signals. In Korea, exosome products are licensed as cosmetics for topical use, not approved for injection, and stem cell products are regulated cell therapies. Neither is proven for vaginal use. Somssi Women's Clinic in Gangnam explains both without hype.

Medically reviewed by Dr. Yoon Ho-joo, MD, PhD, OB/GYN specialist, Somssi Women's Clinic · Last updated October 2026

Woman relaxing on a sofa with a cushion, soft afternoon light through curtains
At a glance

Key facts

The essentials, based on how Somssi Women's Clinic performs this procedure or answers this question. Your plan is confirmed at consultation.

  • Stem cells: Living cells from your own fat or marrow, or a donor; may be cultured
  • Exosomes: Cell-free vesicles secreted by cells; typically from donor cell lines or plants
  • Contains living material? Stem cells yes; exosomes no
  • Regulation in Korea: Stem cells regulated as cell therapy; exosome products licensed as cosmetics for topical use, not injection
  • Evidence for vaginal use: Very limited for both; mostly laboratory or animal data for exosomes
  • Fixes laxity or prolapse: Neither
  • Reviewed by: Dr. Yoon Ho-joo, MD, PhD, OB/GYN specialist

Stem cell therapy injects living cells; exosome therapy injects tiny cell-free packets that cells release, usually produced from donor cell lines or plants. They are marketed side by side as regenerative treatments for vaginal dryness, laxity and sensation, but they are different products with different regulation, and in Korea exosome products are not approved for injection at all.

What stem cells are

Stem cells are cells capable of dividing and developing into other cell types. In clinic marketing the term covers fat tissue injected for its small stromal cell fraction, cells harvested from your fat or bone marrow and expanded in a laboratory, and donor cells from sources such as umbilical cord. Because they are living and sometimes cultured, they are regulated in Korea as cell therapy products by the Ministry of Food and Drug Safety.

What exosomes are

Exosomes are extracellular vesicles: microscopic bubbles of membrane that cells shed, carrying proteins, lipids and fragments of genetic material. They act as messengers between cells. Exosome products for clinics are harvested from cultured cells, often donor-derived stem cell lines, or from plant sources, then filtered and freeze-dried or suspended in a vial.

Exosome products contain no cells, so they are sometimes promoted as a safer, cell-free way to get stem cell benefits. Their composition varies greatly from batch to batch and manufacturer to manufacturer, and what is in a given vial is hard to verify. In Korea, as in the United States, exosome products on the market are licensed as cosmetics for topical application; no exosome product is approved for injection, and regulators have warned against it.

Side-by-side comparison

Feature Stem cell therapy Exosomes
What is injected Living cells Cell-free vesicles
Usual source Your fat or marrow; sometimes donor Donor cell cultures or plants
Proposed action Cells release growth factors and may integrate Vesicles deliver signals to local cells
Evidence for vaginal use Case series, very small studies Laboratory and animal data; human data scarce
Regulation in Korea Cell therapy product; approval for vaginal use generally absent Cosmetic for topical use; not approved for injection
Key risks Contamination, immune reaction, unwanted growth, unknown long-term effects Unknown composition, immune reaction, contamination, batch variability
Durability Unknown Unknown
Fixes structural laxity or prolapse No No

The regulatory point matters

When a treatment has not been approved for a use, the clinic is injecting a product outside its licensed purpose. For exosomes that means a cosmetic, intended for skin surface, placed inside tissue. There is no guarantee of sterility standards appropriate for injection, no agreed dose and no safety data from large numbers of women. Both the Korean Ministry of Food and Drug Safety and the US FDA have warned clinics and consumers about this.

Ask any clinic offering vaginal exosome injections to show the approval document for the product and the injected route. If it cannot, you have your answer. Our pre-treatment checklist walks through the other questions to ask.

Where exosomes are legitimately used

Topical exosome preparations are applied after skin procedures such as laser or microneedling to soothe and support healing, within their cosmetic license. Some clinics apply them to the vulvar skin after energy-based treatments in the same way. That is a different matter from injecting them into the vaginal wall, and the evidence for benefit even in topical use is limited.

Which should you choose?

For most women, neither. If a regenerative injection is reasonable for your symptom, platelet-rich plasma from your own blood is lower-risk, cheaper and better studied than either cultured cells or exosomes; see stem cell therapy versus PRP. If your symptom is menopausal dryness, local estrogen has far stronger evidence. If your symptom is looseness, a bulge or a descended uterus, the only treatment that changes structure is surgery.

How Somssi handles these products

Somssi Women's Clinic is a surgical gynecology clinic in Gangnam, Seoul, founded in 2000 and led by Dr. Yoon Ho-joo, MD, PhD. We do not inject exosome products into the vagina and we do not inject cultured stem cells. Our regenerative offerings are an intravenous autologous NK immune-cell program for immune support and intimate volume options using your own plasma or fat, each named in writing.

What we do first is examine. Vaginal length, width and wall thickness, pelvic floor strength and the position of the uterus are measured, and a pelvic ultrasound is done. The thinned posterior wall and descended cervix that we find in many women asking about regenerative injections are treated with autologous-tissue vaginoplasty, and we explain why no vial would achieve the same.

Bottom line

Stem cells are living cells; exosomes are cell-free vesicles made mostly from donor or plant cultures. In Korea the first is a tightly regulated cell therapy and the second is a cosmetic not approved for injection. Neither is proven for vaginal use and neither repairs structure. Ask for approval documents, prefer your own tissue if you proceed with any injection, and get examined before deciding. Contact Somssi for an honest assessment.

Private consultation

Talk it through with Dr. Yoon's team

English-speaking coordinators, a written treatment plan and a clear quote after your consultation. Same-day discharge for most procedures.

Mon, Tue, Wed, Fri, Sat 09:30–18:00 (KST). Closed Thu, Sun and holidays. 7F Sangkyung Building, 120 Teheran-ro, Gangnam-gu, Seoul.

Dr. Yoon Ho-joo, MD, PhD, director of Somssi Women's Clinic

Dr. Yoon Ho-joo, MD, PhD

OB/GYN specialist, Catholic University of Korea. Founder of Somssi Women's Clinic (2000). Published on female sexual function after reconstructive vaginal surgery; speaker at ESSM, ISSWSH, WAS and SMSNA.

Read Dr. Yoon's profile →

Questions patients ask

Frequently asked questions

Short, honest answers. For anything personal, a consultation is the right place to ask.

See the full FAQ →

Are exosomes safer than stem cells because they contain no cells?

Not necessarily. They avoid the risk of living cells dividing where they should not, but they introduce batch variability, unknown composition and donor-derived material, and they are not manufactured to injectable standards when licensed as cosmetics. The absence of cells does not make an unapproved injection safe.

Are exosome injections approved anywhere for vaginal use?

Not to our knowledge. In Korea and the United States exosome products are marketed as cosmetics for topical use, and regulators in both countries have warned against injecting them. If a clinic claims approval, ask to see the document naming the product and the injected route.

Do exosomes come from human donors?

Many are harvested from cultured human cell lines, including donor stem cells; others come from plant sources. Products rarely state this clearly. Donor origin raises questions about screening, immune reaction and consent that you are entitled to have answered before anything is injected.

Can exosomes tighten the vagina after childbirth?

No. Vaginal laxity after childbirth is a change in stretched muscle and connective tissue, and no vesicle or growth factor can shorten or re-suspend it. Somssi's posterior vaginoplasty thickens the lower wall with your own tissue and restores pelvic floor support; that is what changes the structure.

What should I do if I already had exosome injections?

If you have no symptoms, no action is needed; keep any paperwork. If you have lumps, pain, inflammation or recurrent infection, book an examination. Dr. Yoon can assess the tissue and advise on treatment, and we will record what was injected if you know it.

October 2026
Keep reading

Related treatments and guides

Sources and medical review

  • US Food and Drug Administration (FDA), public safety notification on exosome products and consumer warnings on unapproved regenerative therapies.
  • American College of Obstetricians and Gynecologists (ACOG), guidance on elective female genital cosmetic procedures.
  • Te Linde's Operative Gynecology (textbook), chapters on vaginal anatomy and posterior repair.
Next step

A consultation first. A decision only when you are ready.

Tell us what you are experiencing and what you hope to change. Dr. Yoon examines, measures and explains the options, including when no surgery is the right answer. International patients can start with an online consultation before travelling to Seoul.